Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan D Madanick

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2012
Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagusWilliam J Bulsiewicz, Hannah P Kim, Evan S Dellon, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2019
Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure ProphylaxisNithya Srinivas, Mackenzie Cottrell, Kaitlyn Maffuid, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2013
Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosingBenjamin N Greener, Kristine B Patterson, Heather M A Prince, et al.
Antiviral Therapy|May 2, 2018
Virological and immunological responses to raltegravir and dolutegravir in the gut-associated lymphoid tissue of HIV-infected men and womenMichael D Weber, Elizabeth Andrews, Heather A Prince, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 22, 2016
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial DesignMackenzie L Cottrell, Heather M A Prince, Andrew Allmon, et al.
The Journal of Infectious Diseases|February 27, 2016
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without EmtricitabineMackenzie L Cottrell, Kuo H Yang, Heather M A Prince, et al.
Gastrointestinal Endoscopy|April 6, 2015
Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA RegistrySarina Pasricha, Nan Li, William J Bulsiewicz, et al.
Gastroenterology|September 22, 2010
Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurementsNeil G Terry, Yizheng Zhu, Matthew T Rinehart, et al.
The New England Journal of Medicine|May 29, 2009
Radiofrequency ablation in Barrett's esophagus with dysplasiaNicholas J Shaheen, Prateek Sharma, Bergein F Overholt, et al.
Gastroenterology|June 18, 2011
Durability of radiofrequency ablation in Barrett's esophagus with dysplasiaNicholas J Shaheen, Bergein F Overholt, Richard E Sampliner, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 30, 2012
Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagusWilliam J Bulsiewicz, Hannah P Kim, Evan S Dellon, et al.
Antimicrobial Agents and Chemotherapy|November 20, 2019
Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure ProphylaxisNithya Srinivas, Mackenzie Cottrell, Kaitlyn Maffuid, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 16, 2013
Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosingBenjamin N Greener, Kristine B Patterson, Heather M A Prince, et al.
Antiviral Therapy|May 2, 2018
Virological and immunological responses to raltegravir and dolutegravir in the gut-associated lymphoid tissue of HIV-infected men and womenMichael D Weber, Elizabeth Andrews, Heather A Prince, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 22, 2016
Cervicovaginal and Rectal Fluid as a Surrogate Marker of Antiretroviral Tissue Concentration: Implications for Clinical Trial DesignMackenzie L Cottrell, Heather M A Prince, Andrew Allmon, et al.
The Journal of Infectious Diseases|February 27, 2016
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without EmtricitabineMackenzie L Cottrell, Kuo H Yang, Heather M A Prince, et al.
Gastrointestinal Endoscopy|April 6, 2015
Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA RegistrySarina Pasricha, Nan Li, William J Bulsiewicz, et al.
Gastroenterology|September 22, 2010
Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurementsNeil G Terry, Yizheng Zhu, Matthew T Rinehart, et al.
The New England Journal of Medicine|May 29, 2009
Radiofrequency ablation in Barrett's esophagus with dysplasiaNicholas J Shaheen, Prateek Sharma, Bergein F Overholt, et al.
Gastroenterology|June 18, 2011
Durability of radiofrequency ablation in Barrett's esophagus with dysplasiaNicholas J Shaheen, Bergein F Overholt, Richard E Sampliner, et al.
Pageof 3